28 employees
Renibus Therapeutics is a clinical-stage biotech company focused on preventing and treating kidney disease.
2016
$10M
from 1 investors over 1 rounds
Renibus Therapeutics Inc raised $10M on November 14, 2022
Investors: Oxford Finance LLC